Target intelligence / Profile preview

Promyelocytic leukemia protein (PML) (PML)

Target
PML
Molecular classification
Transcription factor, Scaffold protein, Tripartite motif (TRIM) family, E3 ubiquitin-protein ligase
01

Overview

The Promyelocytic leukemia protein (PML) is a tumor suppressor and the primary structural component of PML nuclear bodies (PML-NBs), which are subnuclear organelles involved in various cellular processes (UniProt P29590). PML functions as a scaffold, recruiting numerous proteins to regulate apoptosis, cellular senescence, DNA damage repair, and antiviral responses (PubMed: 25324444). In Acute Promyelocytic Leukemia (APL), a chromosomal translocation typically fuses the PML gene with the Retinoic Acid Receptor Alpha (RARA) gene, creating the PML-RARA oncoprotein that disrupts normal PML-NB formation (NIH: NBK1404). Therapeutic agents like arsenic trioxide directly target the PML moiety of both the fusion protein and the wild-type protein, inducing their degradation and restoring cellular differentiation (Science, 2010, 328(5975):240-243). Beyond APL, wild-type PML is increasingly recognized for its role in solid tumors and as a potential target in viral infections and other malignancies (Nature Reviews Cancer, 2011, 11(11):797-811). The protein contains a tripartite motif (TRIM) consisting of a RING finger, two B-box zinc fingers, and a coiled-coil domain, which are essential for its multimerization and function (PubMed: 10644755). Loss of wild-type PML expression is observed in many human cancers, correlating with poor prognosis and tumor progression (PubMed: 15064413). Research continues to explore the therapeutic potential of modulating wild-type PML levels in non-APL contexts to exploit its tumor-suppressive properties.

Other names
TRIM19Tripartite motif-containing protein 19MYLRNF71Protein P8675
02

Mechanism of action

Arsenic trioxide binds directly to the cysteine residues within the zinc fingers of the PML B2 domain, which triggers the recruitment of SUMO-conjugating enzymes, leading to hyper-SUMOylation of the protein. This modification facilitates the recruitment of the E3 ubiquitin ligase RNF4, resulting in the polyubiquitination and subsequent proteasomal degradation of the PML protein (Science, 2010, 328(5975):240-243; PubMed: 18408710).

03

Biological functions

ApoptosisCell cycle regulationCellular senescenceDNA damage responseAntiviral responseTumor suppression
04

Disease associations

Acute promyelocytic leukemiaSolid tumorsViral infectionNeurodegenerative disease
05

Safety considerations

Differentiation syndromeQT interval prolongationHepatotoxicitySecondary malignancies
06

Interacting drugs

Arsenic trioxide

1 more in the full profile.

07

Biomarkers

PML-RARA fusion transcriptPML nuclear body morphologyPML protein expression levels

Beyond the preview

Go deeper on Promyelocytic leukemia protein (PML) (PML).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Promyelocytic leukemia protein (PML) (PML).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call